Gewählte Publikation:
Winklhofer-Roob, BM; Ellemunter, H; Frühwirth, M; Schlegel-Haueter, SE; Khoschsorur, G; van't Hof, MA; Shmerling, DH.
Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation.
Am J Clin Nutr. 1997; 65(6): 1858-1866.
Doi: 10.1093/ajcn/65.6.1858
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Khoschsorur Gholamali
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Vitamin C status and possible associations with the disease process in cystic fibrosis (CF) patients were investigated. Plasma vitamin C concentrations in patients from two different mid-European populations (Swiss, n = 62; Austrian, n = 60) taking no or low-dose vitamin C from multivitamin supplements did not differ from each other or from control subjects (n = 34). Vitamin C concentrations decreased with age (5.05 mumol.L-1, y-1). When followed up for 12 mo, patients had the highest plasma vitamin C concentrations in February and the lowest in May and August (P < 0.01); the decrease in vitamin C was accompanied by increases in plasma malondialdehyde (P < 0.001) and tumor necrosis factor alpha concentrations (P < 0.01). During supplementation with vitamin E for 2 mo or beta-carotene for 12 mo vitamin C concentrations did not change. They correlated inversely with white blood cell count (r = -0.36, P = 0.008), bands (r = -0.36, P = 0.02), alpha 1-acid glycoprotein (r = -0.45, P = 0.002), interleukin 6 (r = -0.46, P = 0.0006), and neutrophil elastase/alpha 1-proteinase inhibitor complexes (r = -0.34, P = 0.02). In patients with vitamin C concentrations < 40 mumol/L, all indexes of inflammation were relatively high, whereas those with concentrations > 80 mumol/L (upper quartile of control subjects) showed clearly lower values. These results are consistent with the hypothesis that by scavenging oxygen free radicals vitamin C interacts with an inflammation-amplifying cycle of activation of alveolar macrophages and neutrophils, release of proinflammatory cytokines and oxygen free radicals, and inactivation of antiproteases.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adolescent -
-
Adult -
-
Ascorbic Acid - blood
-
Child - blood
-
Child, Preschool - blood
-
Cohort Studies - blood
-
Cystic Fibrosis - blood
-
Cytokines - metabolism
-
Dose-Response Relationship, Drug - metabolism
-
Female - metabolism
-
Humans - metabolism
-
Infant - metabolism
-
Inflammation - blood
-
Interleukin-6 - blood
-
Leukocyte Elastase - blood
-
Lipid Peroxidation - physiology
-
Lung Diseases - blood
-
Male - blood
-
Malondialdehyde - blood
-
Nutritional Status - blood
-
Orosomucoid - analysis
-
Seasons - analysis
-
Tumor Necrosis Factor-alpha - analysis
-
Vitamin E - administration and dosage
-
beta Carotene - administration and dosage
- Find related publications in this database (Keywords)
-
cystic fibrosis
-
vitamin C
-
inflammation
-
free radicals
-
cytokines
-
malondialdehyde
-
neutrophil elastase alpha(1)-proteinase inhibitor complexes
-
Shwachman score
-
tumor necrosis factor alpha